These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7066914)

  • 1. Development of a model to simulate the characteristics of rat liver tumor promotion by phenobarbital.
    Stevens FJ; Peraino C
    Carcinog Compr Surv; 1982; 7():105-9. PubMed ID: 7066914
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Kunz W; Schaude G; Schwarz M; Tennekes H
    Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
    [No Abstract]   [Full Text] [Related]  

  • 3. Properties of incomplete carcinogens and promoters in hepatocarcinogenesis.
    Pitot HC; Goldsworthy T; Moran S; Sirica AE; Weeks J
    Carcinog Compr Surv; 1982; 7():85-98. PubMed ID: 6802499
    [No Abstract]   [Full Text] [Related]  

  • 4. Initiation and promotion of liver tumorigenesis.
    Peraino C
    Natl Cancer Inst Monogr; 1981 Dec; (58):55-61. PubMed ID: 7341984
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of the effects of promoting agents on liver and urinary bladder carcinogenesis in rats.
    Ito N; Tatematsu M; Nakanishi K; Tsuda H
    Carcinog Compr Surv; 1982; 7():133-7. PubMed ID: 7066916
    [No Abstract]   [Full Text] [Related]  

  • 6. Promotion of chemically initiated hepatocarcinogenesis.
    de Gerlache J; Lans M; Taper H; Préat V; Roberfroid M
    Prog Clin Biol Res; 1982; 109():35-46. PubMed ID: 6132401
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of varying the onset and duration of exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis.
    Peraino C; Fry RJ; Staffeldt E
    Cancer Res; 1977 Oct; 37(10):3623-7. PubMed ID: 908010
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin, and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat.
    Peraino C; Fry RJ; Staffeldt E; Christopher JP
    Cancer Res; 1975 Oct; 35(10):2884-90. PubMed ID: 1157054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of varying the exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat.
    Peraino C; Fry RJ; Staffeldt E; Kisieleski WE
    Cancer Res; 1973 Nov; 33(11):2701-5. PubMed ID: 4748431
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects.
    Williams GM; Katayama S; Ohmori T
    Carcinogenesis; 1981; 2(11):1111-7. PubMed ID: 6119166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and morphologic studies of hepatocarcinogenesis in the rat. ANL-7409.
    Peraino C
    ANL Rep; 1967; ():165-6. PubMed ID: 5308222
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and assessment of tumor-promoting and cocarcinogenic agents: state-of-the-art in vitro methods.
    Bohrman JS
    Crit Rev Toxicol; 1983; 11(2):121-67. PubMed ID: 6340968
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphological classification of mouse liver tumors based on biological characteristics.
    Becker FF
    Cancer Res; 1982 Oct; 42(10):3918-23. PubMed ID: 7104991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of hepatocarcinogens on the central effects of phenobarbital an D-amphetamine.
    Gurkalo VK
    Neoplasma; 1980; 27(5):543-8. PubMed ID: 7231611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of azo-dye hepatocarcinogenesis with dietary phenobarbital in rats.
    Kitagawa T; Sugano H
    Gan; 1977 Apr; 68(2):255-6. PubMed ID: 142681
    [No Abstract]   [Full Text] [Related]  

  • 16. Two-stage and Weibull models for carcinogenesis applied to the ED01 discontinued dosing data.
    Kodell RL; Felton RP
    Environ Health Perspect; 1991 May; 92():155-66. PubMed ID: 1935845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing effect of chemicals on production of hyperplastic liver nodules induced by n-2-fluorenylacetamide in hepatectomized rats.
    Ito N; Tatematsu M; Hirose M; Nakanishi K; Murasaki G
    Gan; 1978 Feb; 69(1):143-4. PubMed ID: 416986
    [No Abstract]   [Full Text] [Related]  

  • 18. Re-examination of the ED01 study--technical discussion of the statistical analysis for adjusting for time on study.
    Fundam Appl Toxicol; 1981; 1(1):81-7. PubMed ID: 7184777
    [No Abstract]   [Full Text] [Related]  

  • 19. Liver tumor promoters stimulate growth of transplanted hepatocellular carcinomas.
    Seglen PO; Saeter G; Schwarze PE
    Hepatology; 1990 Aug; 12(2):295-300. PubMed ID: 2167869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone.
    McLean AE; Marshall A
    Br J Exp Pathol; 1971 Jun; 52(3):323-9. PubMed ID: 5090689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.